ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country

OBJECTIVES: To evaluate the performance and treatment profile of advanced EML4—ALK positive Non-small cell lung cancer (NSCLC) patients in a developing country with potentially restricted access to Crizotinib. MATERIALS AND METHODS: A retrospective analysis of advanced ALK positive NSCLC patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Noronha, Vanita, Ramaswamy, Anant, Patil, Vijay M, Joshi, Amit, Chougule, Anuradha, Kane, Subhadha, Kumar, Rajiv, Sahu, Arvind, Doshi, Vipul, Nayak, Lingaraj, Mahajan, Abhishek, Janu, Amit, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026380/
https://www.ncbi.nlm.nih.gov/pubmed/27637025
http://dx.doi.org/10.1371/journal.pone.0160752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026380/
https://www.ncbi.nlm.nih.gov/pubmed/27637025
http://dx.doi.org/10.1371/journal.pone.0160752

Ejemplares similares